EXECUTIVE SUMMARY OF THE REPORT “THE VALUE OF CLINICAL TRIALS IN DENMARK” AVAILABLE

NEXT, The Danish Association of the Pharmaceutical Industry (Lif) and Invest in Denmark published a report made by Copenhagen Economics in March 2017 in Danish.
The report quantifies the value generated by clinical trials in Denmark, and main conclusions are that clinical trials by pharmaceutical companies deliver value to the Danish society. On average, a clinical trial improves GDP by DKK 0.9m and the public budget by DKK 1.2m.
The positive economic effects arise from trials conducted in Denmark through several drivers: More and better healthcare, highly productive jobs and new research in Life Sciences.
The executive summary is now available in English.

Download (PDF, 452KB)